Madamsetty, V.S.; Rachamala, H.K.; Dutta, S.K.; Wang, E.; Pal, K.; Mukhopadhyay, D.
Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2025, 17, 1334.
https://doi.org/10.3390/pharmaceutics17101334
AMA Style
Madamsetty VS, Rachamala HK, Dutta SK, Wang E, Pal K, Mukhopadhyay D.
Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma. Pharmaceutics. 2025; 17(10):1334.
https://doi.org/10.3390/pharmaceutics17101334
Chicago/Turabian Style
Madamsetty, Vijay Sagar, Hari Krishnareddy Rachamala, Shamit Kumar Dutta, Enfeng Wang, Krishnendu Pal, and Debabrata Mukhopadhyay.
2025. "Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma" Pharmaceutics 17, no. 10: 1334.
https://doi.org/10.3390/pharmaceutics17101334
APA Style
Madamsetty, V. S., Rachamala, H. K., Dutta, S. K., Wang, E., Pal, K., & Mukhopadhyay, D.
(2025). Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma. Pharmaceutics, 17(10), 1334.
https://doi.org/10.3390/pharmaceutics17101334